Piloting JUN_Pregnancy Mobile Medical App
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO · Oct 8, 2024
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new mobile app called JUN, designed to help pregnant women track their symptoms and receive important information during their pregnancy. The app uses artificial intelligence (AI) to provide personalized feedback and education to support women in making decisions about their health. Researchers want to find out how well the app works for women who are on community supervision, like probation or parole, compared to those who are not.
To participate in the trial, women need to be between the ages of 18 and 50 and in the first six months of their pregnancy. They can live in Texas, Minnesota, or Oregon. The study is currently looking for pregnant women who fit these criteria. Participants will use the JUN app and share their experiences, helping researchers understand its effectiveness and safety. This trial is a great opportunity for pregnant women to access support and education during their pregnancy while contributing to important research.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Pregnant female 18-50 years
- • 2. Within first 6 months of pregnancy
- • 3. Either on community supervision or without criminal system involvement
- • 4. Located in Texas, Minnesota or Oregon
- Exclusion Criteria:
- • 1. Individuals who do not identify as women
- • 2. Later pregnancy, beyond the first 6 months
About The University Of Texas Health Science Center At San Antonio
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is a leading academic medical institution dedicated to advancing health through education, research, and patient care. As a prominent sponsor of clinical trials, UT Health San Antonio focuses on innovative medical research aimed at improving health outcomes across diverse populations. With a commitment to excellence, the institution fosters collaboration among its multidisciplinary teams to explore cutting-edge therapies and interventions. Through rigorous scientific inquiry and ethical practices, UT Health San Antonio strives to make meaningful contributions to the field of medicine and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Patients applied
Trial Officials
Allison Crawford, PhD
Principal Investigator
The University of Texas Health Science Center at San Antonio
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported